Search
for
Sort by
Research 871–900 of 1000+
- Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Skin manifestations associated with systemic diseases – Part I
- Expanding the phenotype: Four new cases and hope for treatment in Bachmann‐Bupp syndrome
- Effect of Bariatric Surgery on Weight Loss, Nutritional Deficiencies, Postoperative Complications and Adherence to Dietary and Lifestyle Recommendations: A retrospective cohort study from Bahrain
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Topical and Systemic Therapies in Melasma: A Systematic Review
- Case Report: Analytically Confirmed Severe Albenzadole Overdose Presenting with Alopecia and Pancytopenia
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Selenium Compounds and Their Bioactivities: Molecular Mechanisms and Prospects for Functional Food and Therapeutic Applications
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions